Understand the source comparison
Glow Stack Concentration: Research Protocol Comparison
Acute receptor activation assay 100–200 μg/mL 15–60 minutes Maximal receptor occupancy, peak signalling pathway activation High concentration acceptable for short-term studies where chronic effects are not relevant Chronic exposure study (metabolic modulation)
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Acute receptor activation assay
- 100–200 μg/mL
- 15–60 minutes
- Maximal receptor occupancy, peak signalling pathway activation
- High concentration acceptable for short-term studies where chronic effects are not relevant
- Chronic exposure study (metabolic modulation)
- 25–50 μg/mL
- 24–72 hours
- Sustained pathway activation without receptor desensitization
- Lower concentration mimics physiological conditions and reduces off-target effects
- Dose-response curve generation
- 10–500 μg/mL (serial dilution)
- Varies by endpoint
- EC50 determination, therapeutic window identification
- Wide range required to map full dose-response relationship
- Combination synergy testing
- 50–100 μg/mL (each compound)
- 24–48 hours
- Interaction effects, synergistic vs additive response
- Mid-range concentration avoids saturation while ensuring measurable signal
- Long-term tissue culture (7+ days)
- 10–25 μg/mL
- 7–14 days
- Chronic pathway modulation without cytotoxicity
- Very low concentration required to prevent metabolic stress and maintain cell viability